Sherman Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$188K Sell
519
-176
-25% -$60.2K 0.15% 56
2026
Q1
$245K Hold
695
– – 0.23% 44
2025
Q4
$227K Hold
695
– – 0.19% 51
2025
Q3
$196K Hold
695
– – 0.17% 54
2025
Q2
$194K Hold
695
– – 0.17% 59
2025
Q1
$217K Hold
695
– – 0.21% 53
2024
Q4
$181K Buy
+695
New +$206K 0.17% 61

Other funds holding AMGN

Sherman Asset Management's AMGN Position: Q2 2026 in Review

Sherman Asset Management reduced its Amgen (AMGN) stake by 25% in Q2 2026, selling an estimated $60.2K and leaving 519 shares worth $188K. The position accounts for 0.15% of the portfolio, ranked #56.

Sherman Asset Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $245K in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sherman Asset Management held 519 shares of Amgen worth $188K as of Q2 2026.
  • Sherman Asset Management sold 176 Amgen shares in Q2 2026, an estimated $60.2K.
  • Amgen made up 0.15% of Sherman Asset Management's portfolio in Q2 2026, its #56 holding.
  • Sherman Asset Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Sherman Asset Management's Amgen position peaked at $245K in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sherman Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.